Jeffrey E. Russel

Array ( [id] => 5279205 [patent_doc_number] => 20090131337 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'HAIR GROWTH COMPOSITION' [patent_app_type] => utility [patent_app_number] => 12/330054 [patent_app_country] => US [patent_app_date] => 2008-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3523 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131337.pdf [firstpage_image] =>[orig_patent_app_number] => 12330054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6087977 [patent_doc_number] => 20110217324 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'INHIBITORS OF ANTIGEN PRESENTATION BY MHC CLASS II MOLECULES AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/745562 [patent_app_country] => US [patent_app_date] => 2008-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20921 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20110217324.pdf [firstpage_image] =>[orig_patent_app_number] => 12745562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8282899 [patent_doc_number] => 08216999 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-10 [patent_title] => 'HCV NS3 protease inhibitors' [patent_app_type] => utility [patent_app_number] => 12/325965 [patent_app_country] => US [patent_app_date] => 2008-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42024 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12325965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5509102 [patent_doc_number] => 20090082309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'Method of Regulating Glucose Metabolism, and Reagents Related Thereto' [patent_app_type] => utility [patent_app_number] => 12/323751 [patent_app_country] => US [patent_app_date] => 2008-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19035 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20090082309.pdf [firstpage_image] =>[orig_patent_app_number] => 12323751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5580478 [patent_doc_number] => 20090175824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'Peptides for the treatment of HCV infections' [patent_app_type] => utility [patent_app_number] => 12/313507 [patent_app_country] => US [patent_app_date] => 2008-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13363 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20090175824.pdf [firstpage_image] =>[orig_patent_app_number] => 12313507 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5316435 [patent_doc_number] => 20090281033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'Control of radiation injury' [patent_app_type] => utility [patent_app_number] => 12/288935 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 23384 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20090281033.pdf [firstpage_image] =>[orig_patent_app_number] => 12288935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8664606 [patent_doc_number] => 08378066 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-19 [patent_title] => 'Insulinotropic peptide synthesis using solid and solution phase combination techniques' [patent_app_type] => utility [patent_app_number] => 12/288934 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 20320 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12288934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7687586 [patent_doc_number] => 20090176705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'MODULAR PLATFORM FOR TARGETED THERAPEUTIC DELIVERY' [patent_app_type] => utility [patent_app_number] => 12/255947 [patent_app_country] => US [patent_app_date] => 2008-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11352 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20090176705.pdf [firstpage_image] =>[orig_patent_app_number] => 12255947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7987981 [patent_doc_number] => 08076285 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-13 [patent_title] => 'Lysobactin amides' [patent_app_type] => utility [patent_app_number] => 12/249888 [patent_app_country] => US [patent_app_date] => 2008-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 98368 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/076/08076285.pdf [firstpage_image] =>[orig_patent_app_number] => 12249888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4639545 [patent_doc_number] => 08017572 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-13 [patent_title] => 'Immune-modulating peptide' [patent_app_type] => utility [patent_app_number] => 12/246229 [patent_app_country] => US [patent_app_date] => 2008-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 26 [patent_no_of_words] => 12735 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/017/08017572.pdf [firstpage_image] =>[orig_patent_app_number] => 12246229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6578234 [patent_doc_number] => 20100047330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'TREATMENT FOR DARK ADAPTATION' [patent_app_type] => utility [patent_app_number] => 12/245944 [patent_app_country] => US [patent_app_date] => 2008-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 17156 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047330.pdf [firstpage_image] =>[orig_patent_app_number] => 12245944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 132825 [patent_doc_number] => 07696162 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-13 [patent_title] => 'Zinc-free and low-zinc insulin preparations having improved stability' [patent_app_type] => utility [patent_app_number] => 12/285464 [patent_app_country] => US [patent_app_date] => 2008-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5877 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/696/07696162.pdf [firstpage_image] =>[orig_patent_app_number] => 12285464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564616 [patent_doc_number] => 20090137469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Use of ADNF polypeptides for treating peripheral neurotoxicity' [patent_app_type] => utility [patent_app_number] => 12/245517 [patent_app_country] => US [patent_app_date] => 2008-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12837 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137469.pdf [firstpage_image] =>[orig_patent_app_number] => 12245517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6433632 [patent_doc_number] => 20100278807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'Novel antimicrobial agents' [patent_app_type] => utility [patent_app_number] => 12/232383 [patent_app_country] => US [patent_app_date] => 2008-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 28654 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0278/20100278807.pdf [firstpage_image] =>[orig_patent_app_number] => 12232383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5502728 [patent_doc_number] => 20090163416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'Use of a ghrelin agonist to improve the catabolic effects of glucocorticoid treatment' [patent_app_type] => utility [patent_app_number] => 12/283161 [patent_app_country] => US [patent_app_date] => 2008-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16857 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20090163416.pdf [firstpage_image] =>[orig_patent_app_number] => 12283161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6535675 [patent_doc_number] => 20100204158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'COMBINATION OF SPLENOPENTIN AND THYMOPENTIN AND THE USE THEREOF IN MEDICINE' [patent_app_type] => utility [patent_app_number] => 12/677806 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35624 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204158.pdf [firstpage_image] =>[orig_patent_app_number] => 12677806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5324525 [patent_doc_number] => 20090062515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'METHOD FOR PURIFYING BIOACTIVE SUBSTANCES' [patent_app_type] => utility [patent_app_number] => 12/201594 [patent_app_country] => US [patent_app_date] => 2008-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6525 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062515.pdf [firstpage_image] =>[orig_patent_app_number] => 12201594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6002793 [patent_doc_number] => 20110118173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'METHOD OF DELIPIDATION OF HDL USING SERUM OPACITY FACTOR TO PREVENT, INHIBIT, AND/OR REVERSE ATHEROSCLEROSIS' [patent_app_type] => utility [patent_app_number] => 12/674469 [patent_app_country] => US [patent_app_date] => 2008-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 40001 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20110118173.pdf [firstpage_image] =>[orig_patent_app_number] => 12674469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539705 [patent_doc_number] => 20090221510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'ERYTHROPOIETIN RECEPTOR PEPTIDE FORMULATIONS AND USES' [patent_app_type] => utility [patent_app_number] => 12/195832 [patent_app_country] => US [patent_app_date] => 2008-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 20711 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221510.pdf [firstpage_image] =>[orig_patent_app_number] => 12195832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5354652 [patent_doc_number] => 20090185996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'HYDROXYETHYL STARCH-CONTAINING POLYPEPTIDE COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/193987 [patent_app_country] => US [patent_app_date] => 2008-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7849 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20090185996.pdf [firstpage_image] =>[orig_patent_app_number] => 12193987 [rel_patent_id] =>[rel_patent_doc_number] =>)